search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


49 resulaten gevonden voor Roche Nederland BV in trials

Chemotherapy and surgery versus surgery alone for colorectal cancer with metastases in the peritoneum
- TRIAL ID
NTR6301
- ACRONYMCAIRO6
Genetic variations as predictors of outcome and toxicity in non-small-cell lung cancer patients undergoing chemoradiation or chemotherapy with platinum agents.
- TRIAL ID
NTR5836
- ACRONYMPGx Lung cancer
MaxABC study: Effect of Automated Bolus Calculation on glycemic variability and relation with psychological problems
- TRIAL ID
NTR4730
- ACRONYMsensor BolusCal glucose variabillity welbeiing
A randomized phase II study for evaluation of T cell depleted non myeloablative allogeneic stem cell transplantation followed by early consolidation with lenalidomide or lenalidomide combined with bortezomib and subsequent DLI for patients with multiple myeloma in progression or relapse following first line therapy.
- TRIAL ID
NTR2958
- ACRONYMHOVON 108 MM
An open randomized phase III study to compare 8 continuous cycles of chemotherapy with 8 cycles of intermittent (2 times 4 cycles) chemotherapy in first line treatment, in combination with bevacizumab, and second line treatment of patients with HER2/neu negative, incurable, metastatic or unresectable locally advanced breast cancer.
- TRIAL ID
NTR2589
- ACRONYMStop&Go
A randomized phase III study to compare Bortezomib, Melphalan, Prednisone (VMP) with High Dose Melphalan followed by Bortezomib, Lenalidomide, Dexamethasone (VRD) consolidation and Lenalidomide maintenance in patients with newly diagnosed multiple myeloma.
- TRIAL ID
NTR2528
- ACRONYMHOVON 95 MM
Rituximab in Primary Central Nervous system Lymphoma. A randomized HOVON / ALLG intergroup study.
- TRIAL ID
NTR2427
- ACRONYMHOVON 105 PCNSL
Adherence and patients’ experiences with capecitabine.
- TRIAL ID
NTR2324
- ACRONYMCaper
The Dutch ITP-registry, a national web-based tool for collection of diagnostic, therapeutical and evaluation data from patients with chronic immune trombocytopenic purpura.
- TRIAL ID
NTR2308
- ACRONYMSTiC registry
A Phase II study combining short course radiotherapy, chemotherapy and resection of the rectum and metastases in primary metastasized rectal cancer.
- TRIAL ID
NTR2029
- ACRONYMM1-study
Bevacizumab versus bevacizumab plus lomustine versus lomustine in recurrent glioblastoma.
- TRIAL ID
NTR1929
- ACRONYMLWNO 0901
Adherence and patients’ experiences with erlotinib.
- TRIAL ID
NTR1830
- ACRONYMCaper
Bortezomib maintenance therapy in newly diagnosed patients with mantle cell lymphoma, responsive on rituximab combined with CHOP and high dose Ara-C and after BEAM with auto PSCT rescue.
- TRIAL ID
NTR1772
- ACRONYMHOVON 75 MCL
Phase II study on the feasibility and efficacy of R-DHAP + HD-MTX, combined with intrathecal rituximab, followed by autologous stem cell transplantation in patients with a recurrent aggressive B-cell lymphoma with CNS localisation.
- TRIAL ID
NTR1757
- ACRONYMHOVON 80 NHL
Open label study to establish the efficacy of intravenous loading doses of Ibandronate 6 mg in patients with lung cancer and skeletal metastases experiencing moderate to severe bone pain: NVALT 9.
- TRIAL ID
NTR1602
- ACRONYMNVALT-9 study
INFLUENCE OF B CELL DEPLETION BY MONOCLONAL ANTI-CD20 ANTIBODIES IN SYSTEMIC SCLERODERMA
- TRIAL ID
NTR1521
- ACRONYMRITIS
Allogeneic Stem Cell Transplantation after Reduced Intensity Conditioning for High- risk Relapsed or Refractory CLLA prospective multi-centre phase II study
- TRIAL ID
NTR1461
- ACRONYMHOVON 88 CLL
Phase I/II trial of Lenalidomide plus Bortezomib combined with Dexamethasone in patients in 1st relapse or primary refractory after first line therapy for Multiple Myeloma.
- TRIAL ID
NTR1440
- ACRONYMHOVON 86 MM
Phase II study on the feasibility and efficacy of consolidation with 90Y-ibritumomab tiuxetan in patients with relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma having achieved partial or complete remission after induction with R-PECC chemotherapy.
- TRIAL ID
NTR1380
- ACRONYMHOVON 85 NHL
A randomized phase II study of concomitant trastuzumab, bevacizumab with paclitaxel versus trastuzumab and bevacizumab followed by the combination of trastuzumab, bevacizumab and paclitaxel at progression as first-line treatment of patients with metastatic breast cancer with HER2-neu overexpression.
- TRIAL ID
NTR1349
- ACRONYMHAT, BOOG 2008-03
Phase II randomized trial of combination therapy of paclitaxel and bevacizumab versus paclitaxel, capecitabine and bevacizumab as first-line treatment for locally recurrent or metastatic breast cancer patients with HER2/neu negative tumor
- TRIAL ID
NTR1348
- ACRONYMATX
A randomised phase II study of pemetrexed compared to pemetrexed-carboplatin in pretreated patients with advanced NSCLC
- TRIAL ID
NTR916
- ACRONYMNVALT-7 study
Peripheral targeting of inhaled rhDNase in stable CF patients.
- TRIAL ID
NTR912
- ACRONYM
Efficacy of Inhaled RhDNase in Mechanically Ventilated Pediatric Patients with an Atelectasis.
- TRIAL ID
NTR725
- ACRONYMN/A
Anti-CD20 therapy for the treatment of chronic graft versus host disease.
- TRIAL ID
NTR709
- ACRONYMR'mabcGVHD
Imatinib in combination with Cytarabine as compared to Imatinib alone in patients with first chronic phase Chronic Myeloid Leukemia. A prospective randomized phase III study.
- TRIAL ID
NTR674
- ACRONYMHOVON 78 CML
Alemtuzumab as remission induction for adult patients with acute lymphoblastic leukemia in relapse; A randomized phase II study.
- TRIAL ID
NTR673
- ACRONYMHOVON 74 ALL
Efficacy of peripherally targeted inhaled rhDNase for persistent obstructive asthma in childhood.
- TRIAL ID
NTR671
- ACRONYMIDOL
Randomized phase III study of Rituximab with intensified CHOP chemotherapy vs. Rituximab with High-Dose Sequential Therapy and Autologous Stem Cell Transplantation in Adult Patients (18-65 yrs) with Stage II-IV High-intermediate or High Risk DLBCL.
- TRIAL ID
NTR556
- ACRONYMHOVON 63 NHL
DIEPTE-study: DNase Inhalation in cf Exacerbations, Peripherally Targeted.
- TRIAL ID
NTR553
- ACRONYMDIEPTE
Simply Capecitabine in rectal cancer after irradiation plus TME.
- TRIAL ID
NTR552
- ACRONYMSCRIPT
A phase II study of erlotinib and bevacizumab in patients with locally advanced and/or metastatic (stage IIIB or IV) Non-Small Cell Lung Cancer (NSCLC) who have not received prior chemotherapy.
- TRIAL ID
NTR528
- ACRONYMPhase II study of erlotinib and bevacizumab as first line treatment in patients with advanced NSCLC.
Response and markers of response in chronic hepatitis B patients treated with Peg-interferon alfa-2a and adefovir.
- TRIAL ID
NTR509
- ACRONYMN/A
Radiotherapy with or without ibandronate in the treatment of painful bone metastases of prostate cancer.
- TRIAL ID
NTR503
- ACRONYMN/A
Randomised multi-centre study comparing mycophenolate and ciclospoine A in children with a frequent relapsing or corticoid dependent idiopathic nephrotic syndrome.
- TRIAL ID
NTR502
- ACRONYMN/A
Novel maintenance Immunosuppression with Controlled systemic Exposure.
- TRIAL ID
NTR480
- ACRONYMNICE
Comparative Pancreas Induction Study.
- TRIAL ID
NTR479
- ACRONYMCOMPAS
Rate Control Efficacy in permanent atrial fibrillation, a comparison between lenient verus strict rate control in patients with and without heart failure.
- TRIAL ID
NTR425
- ACRONYMRACE II
A double-blind, randomized, double dummy, cross over, study to assess the difference in efficacy between nebulisation of rhDNase before airway clearande therapy (ACT)versus nebulisation after ACT.
- TRIAL ID
NTR352
- ACRONYMN/A
Myelo-ablative chemo/radiotherapy and autologous stem cell transplantation as compared to only chemotherapy in patients with multiple myeloma.
- TRIAL ID
NTR321
- ACRONYMHOVON 24 MM
Effect of recombinant G-CSF on the results of chemotherapy (CHOP) in elderly patients with intermediate-/high-grade Non-Hodgkin’s Lymphoma. A prospective phase III study.
- TRIAL ID
NTR320
- ACRONYMHOVON 25 NHL
Open label, comparative, randomized, multicenter, study of trastuzumab given with docetaxel versus sequential single agent therapy with trastuzumab followed by docetaxel as first-line treatment for Her2neu+++ metastatic breast cancer patients.
- TRIAL ID
NTR308
- ACRONYMHERTAX, BOOG 2002-02
Optimal blood management in elective orthopaedic surgery. The Transfusion "Op Maat" (TOMaat) study.
- TRIAL ID
NTR303
- ACRONYMTOMaat study.
Risk adapted treatment of acute myelocytic leukemia (AML).
- TRIAL ID
NTR291
- ACRONYMHOVON 29 AML/SAKK 30/95
High-dose cytarabin versus low-dose cytarabin plus interferon-alpha-2a both followed by maintenance with interferon-alpha-2a in chronic myeloid leukemia.
- TRIAL ID
NTR290
- ACRONYMHOVON 38 CML
Efficacy of inhaled DNase in children with an airway malacia and a lowerrespiratory tract infection.
- TRIAL ID
NTR241
- ACRONYMN/A
Efficacy of inhaled rhDNase for acute asthma in childhood.
- TRIAL ID
NTR240
- ACRONYMN/A
Efficacy of inhaled DNase in admitted infants with RSV-bronchiolitis.
- TRIAL ID
NTR82
- ACRONYMN/A
Effect of increased convective clearance by on-line hemodiafiltration on all cause and cardiovascular mortality in chronic hemodialysis patients. The Dutch CONvective TRAnsport STudy (CONTRAST).
- TRIAL ID
NTR24
- ACRONYMCONTRAST